Available Structures

13 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure of HIV Protease complexed with methyl N-[(1S)-1-benzhydryl-2-[2-[2-[(2R,5S)-5-(be…homo-2-mer1-99
CL;6EF;
Assess
Crystal Structure of HIV Protease complexed with methyl N-[(1S)-1-[[2-[(3S)-3-[(4-aminophenyl)methy…homo-2-mer1-99
CL;6EG;
Assess
X-ray crystal structure of wild type HIV-1 protease in complex with GRL-063homo-2-mer1-99
EDO;MJD;
Assess
Crystal Structure of HIV Protease complexed with methyl N-[(1S)-1-benzhydryl-2-(3-morpholin-4-ium-2…homo-2-mer1-99
6EH;CL;
Assess
Inhibitor of HIV protease with unusual binding mode potently inhibiting multi-resistant protease mu…homo-2-mer1-99
Q50;
Assess
Crystal structure of HIV-1 Protease NL4-3 I50V Mutant in complex with UMass6homo-2-mer1-99
SO4;A60;
Assess
Crystal structure of HIV-1 Protease NL4-3 WT in complex with UMass1homo-2-mer1-99
SO4;K13;
Assess
Crystal structure of HIV-1 Protease NL4-3 I50V Mutant in complex with darunavirhomo-2-mer1-99
SO4;017;
Assess
Crystal structure of HIV-1 Protease NL4-3 WT in complex with UMass6homo-2-mer1-99
SO4;A60;
Assess
Crystal structure of HIV-1 Protease NL4-3 I50V Mutant in complex with UMass1homo-2-mer1-99
SO4;K13;
Assess
HIV-1 Protease NL4-3 WT in complex with darunavirhomo-2-mer1-99
017;
Assess
HIV Protease (PR) dimer in closed form with pepstatin in active site and fragment AK-2097 in the ou…homo-2-mer1-99
K97;GOL;
Assess
HIV Protease (PR) dimer in closed form with TL-3 in active site and fragment AK-2097 in the outside…homo-2-mer1-99
3TL;BME;K97;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4f74.1.Ahomo-2-mer0.851-99
SER;94.95
Assess